Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception

van Vlijmen, E. F. W., Veeger, N. J. G. M., Middeldorp, S., Hamulyák, K., Prins, M. H., Büller, H. R. & Meijer, K., 2011, In: Blood. 118, 8, p. 2055-61; quiz 2375

Research output: Contribution to journal › Article › Academic › peer-review

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

Eerenberg, E. S., Kamphuisen, P. W., Sijpkens, M. K., Meijers, J. C., Buller, H. R. & Levi, M., 2011, In: Circulation. 124, 14, p. 1573-1579

Research output: Contribution to journal › Article › Academic › peer-review

Oral Rivaroxaban for Symptomatic Venous Thromboembolism REPLY

Buller, H. R., Lensing, A. W. A. & Prins, M. H., 2011, In: New England journal of medicine. 364, 12, p. 1178

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

Connolly, S. J., Milling, T. J., Eikelboom, J. W., Gibson, C. M., Curnutte, J. T., Gold, A., Bronson, M. D., Lu, G., Conley, P. B., Verhamme, P., Schmidt, J., Middeldorp, S., Cohen, A. T., Beyer-Westendorf, J., Albaladejo, P., Lopez-Sendon, J., Goodman, S., Leeds, J., Wiens, B. L. & Siegal, D. M. & 6 others, Zotova, E., Meeks, B., Nakamya, J., Lim, W. T., Crowther, M. & AUTHOR GROUP, 2016, In: New England journal of medicine. 375, 12, p. 1131-1141

Research output: Contribution to journal › Article › Academic › peer-review

Thrombosis: a major contributor to global disease burden

Raskob, G. E., Angchaisuksiri, P., Blanco, A. N., Buller, H., Gallus, A., Hunt, B. J., Hylek, E. M., Kakkar, A., Konstantinides, S. V., McCumber, M., Ozaki, Y., Wendelboe, A. & Weitz, J. I., 2014, In: Arteriosclerosis, thrombosis, and vascular biology. 34, 11, p. 2363-2371

Research output: Contribution to journal › Article › Academic › peer-review